Modulation of the proteins released during activation is one mechanism whereby aspirin may influence platelet-mediated human disease. We investigated the effect of aspirin on the platelet releasate using mass spectrometry and found that different agonists evoked different releasate profiles, with aspirin having a general moderating effect on the amount of protein released regardless of the agonist. These observations were confirmed for several cytokines using an antibody array approach.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1182/blood-2006-07-038539 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterisation of Platelet Releasate Proteome in Relapsing-Remitting Multiple Sclerosis Reveals Dysregulation of Inflammatory Signalling and Extracellular Vesicle Dynamics.
Proteomics Clin Appl
January 2025
SPHERE Research Group, Conway Institute, University College Dublin, Dublin, Ireland.
Purpose: Multiple Sclerosis is an inflammatory neurodegenerative disease characterised by blood-brain barrier dysfunction and leukocyte infiltration into the CNS. Platelets are best known for their contributions to haemostasis, however, upon activation, platelets release an abundance of soluble and vesicular-associated proteins, termed the platelet releasate (PR). This milieu contains numerous inflammatory and vasoactive proteins, that can attract leukocytes and alter endothelial permeability.
View Article and Find Full Text PDFAspirin Does Not Inhibit Platelet-Rich Plasma Releasate Efficacy in a Murine Model of Rotator Cuff Tendinopathy.
HSS J
April 2024
Department of Regenerative Medicine, Hospital for Special Surgery, New York, NY, USA.
Background: Platelet-rich plasma (PRP) has been shown to be a promising treatment for subacromial impingement, and although its interaction with aspirin (ASA) is controversial, many providers ask patients to stop non-steroidal anti-inflammatory drug use before PRP administration.
Purpose: This studied aimed to identify the effect of PRP in a murine model of subacromial impingement and to explore the effect of ASA on PRP treatment.
Methods: A murine model of subacromial impingement was used, incorporating 48 wild-type C57BL/6 mice.
Manufacture and Initial Characterisation of RAPID Biodynamic Haematogel, an Autologous Platelet and Leukocyte-Rich Plasma Gel for Diabetic Foot Ulcers.
Gels
September 2024
Institute of Pharmaceutical Science, King's College London, Franklin-Wilkins Building, Stamford Street, London SE1 9NH, UK.
This observational study reports the process for the manufacture of RAPID Biodynamic Haematogel and explores the properties of the platelet and leukocyte-rich plasma gels formed. Gels were manufactured from 60 mL of human blood using the protocol of Biotherapy Services. Platelet and leukocyte content, time-to-gel, gel weight and the temporal profile of liquid exudation from the gels were measured, along with the content of growth factors VEGF and PDGF in the releasate.
View Article and Find Full Text PDFAlterations in visible light exposure modulate platelet function and regulate thrombus formation.
J Thromb Haemost
January 2025
Department of Surgery, Trauma and Transfusion Medicine Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA; University of Pittsburgh Medical School, Pittsburgh, Pennsylvania, USA.
Background: Variations in light exposure are associated with changes in inflammation and coagulation. The impact of light spectra on venous thrombosis (VT) and arterial thrombosis is largely unexplored.
Objectives: To investigate the impact of altering light spectrum on platelet function in thrombosis.
High-Dimensional Single-Cell Mass Cytometry Demonstrates Differential Platelet Functional Phenotypes in Infants With Congenital Heart Disease.
Arterioscler Thromb Vasc Biol
December 2024
Department of Pediatrics (B.S.M., E.V.S.F.), Yale University School of Medicine, New Haven, CT.
Article Synopsis
- Congenital heart disease (CHD) is linked to both clotting and bleeding risks, with past studies showing mixed results on platelet activity in affected infants, prompting this investigation.
- The study enrolled 19 infants with CHD and 21 controls, using advanced mass spectrometry to analyze platelet surface markers and cytokine levels in the blood.
- Results indicated significant differences in platelet activation in CHD infants, revealing unique subpopulations of platelets, increased hypogranular platelets, and elevated plasma cytokines, suggesting complex platelet behavior in this condition.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!